CEACAM5 and colorectal carcinoma: It was found that bacteriophage M13, which targets carcinoembryonic antigen, can specifically bind to the carcinoembryonic antigen in tumor cells, activate antitumor immunity, and substantially inhibit tumor growth in CRC tumor-bearing mice (Murgas et al., 2018).